Depomed rejects Horizon Pharma's latest bid
July 29 (Reuters) - Depomed Inc rejected Horizon Pharma Plc's latest unsolicited bid, saying the offer is "inadequate" and undervalues the company.
Last week, Ireland-based Horizon had raised its offer to acquire the smaller drugmaker.
(Reporting by Natalie Grover in Bengaluru; Editing by Savio D'Souza)